Patents by Inventor Ruggero De Maria Marchiano

Ruggero De Maria Marchiano has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method and a kit to quantify and qualify exosomes for diagnosis of prostate cancer and prostate hyperplasia
    Publication number: 20170307635
    Abstract: A method and a kit are provided to quantify and qualify exosomes. Specifically the method and the kit quantify PSA-carrying exosomes for a purpose to diagnose prostate cancer and to distinguish between patients having a tumor and those having a benign prostate condition with increased blood levels of PSA. The method and the kit provide a fast, easy to use and accurate method for clinical settings.
    Type: Application
    Filed: July 8, 2017
    Publication date: October 26, 2017
    Applicant: Exosomics Siena S.p.A.
    Inventors: Stefano Fais, Mariantonia Logozzi, Ruggero De Maria Marchiano, Desiree Bonci
  • INHIBITOR OF INTEGRIN FOR THE TREATMENT OR PREVENTION OF TUMOURS
    Publication number: 20150315276
    Abstract: The present invention relates to inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours, to composition comprising inhibitors of alpha7 integrin for the treatment, suppression and/or prevention of tumours and to medical treatments comprising administering said inhibitors or compositions to a patient in need thereof, for the treatment, suppression and/or prevention of tumours.
    Type: Application
    Filed: November 8, 2013
    Publication date: November 5, 2015
    Inventors: Ruggero DE MARIA MARCHIANO, Tobias Longin HAAS, Lucia RICCI VITIANI, Mauro BIFFONI
  • MICRORNAS AND USES THEREOF
    Publication number: 20140356459
    Abstract: The invention relates to molecular targets and their use to counteract tumors. Naturally occurring microRNAs that regulate human oncogenes and methods of use thereof are described. Suitable nucleic acids for use in the methods and compositions described herein include, but are not limited to, pri-miRNA, pre-miRNA, mature miRNA or fragments of variants thereof that retain the biological activity of the mature miRNA and DNA encoding a pri-miRNA, pre-miRNA, mature miRNA, fragments or variants thereof, or regulatory elements of the miRNA. The here claimed approach is efficacious also on Cancer Stem Cells.
    Type: Application
    Filed: December 11, 2012
    Publication date: December 4, 2014
    Inventors: Ruggero De Maria Marchiano, Valeria Coppola, Matilde Todaro, Micol Eleonora Fiori, Enrico Garaci
  • Digestive system cancer stem cells and tests and uses therefor
    Patent number: 8357492
    Abstract: The CD133 marker has been found to be diagnostic of tumorigenic digestive system cancers, particularly malignant colorectal cancers. Tests to show such cells and uses for such cells are disclosed.
    Type: Grant
    Filed: September 19, 2007
    Date of Patent: January 22, 2013
    Assignee: Istituto Superiore di Sanita
    Inventor: Ruggero De Maria Marchiano
  • Digestive System Cancer Stem Cells and Tests and Uses Therefor
    Publication number: 20100024049
    Abstract: The CD133 marker has been found to be diagnostic of tumourigenic digestive system cancer, particularly malignant colorectal cancers. Tests to show such cells and uses for such cells are disclosed.
    Type: Application
    Filed: September 19, 2007
    Publication date: January 28, 2010
    Applicant: Istituto Superiore di Sanita
    Inventor: Ruggero De Maria Marchiano